1.Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization.
Journal of Biomedical Engineering 2003;20(1):175-179
DNA vaccination that can induce both cellular and humoral immune response has become an attractive immunization strategy against cancer and infectious disease. Elucidation of the precise mechanisms of immune priming will be important in the development of effective DNA vaccines. In this review, we illustrate possible mechanisms in priming cytotoxic T cell response involving the intracellular degradation, processing and presentation of encoded antigen. We also discuss the roles of costimulatory molecules expressed on antigen-presenting cells (APCs) in inducing optimal CTL activity. Hence, a rational strategy for increasing DNA potency would be to facilitate these pathways. Additionally, we focus on recent strategies including rapid degradation of ubiquitin-antigen fusion proteins, direct targeting to APCs for increased DNA uptake, direct routing an antigen into the MHC class I and II processing and presentation pathways, and increasing the immunogenicity of encoded antigen. All of these approaches have resulted in increased potency of DNA vaccines.
Animals
;
Antigen Presentation
;
Antigen-Presenting Cells
;
immunology
;
Lysosomes
;
immunology
;
Mice
;
T-Lymphocytes, Cytotoxic
;
immunology
;
Ubiquitin
;
physiology
;
Vaccines, DNA
;
genetics
;
immunology
2.The role of dendritic cell and macrophage in hepatoma antigen-presenting.
Yong-guo LI ; Yun-ping LUO ; Zeng-wei LIANG ; Da-chuan CAI ; Ying-hua LAN ; Qun XIE ; Hong REN
Chinese Journal of Hepatology 2003;11(3):139-141
OBJECTIVETo study the role of dendritic cells (DCs) and macrophages, differentiated from the same individual peripheral blood monocytes, in tumor antigen- presenting.
METHODSDCs and macrophages were differentiated from human peripheral blood monocytes by adding both Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) or GM-CSF only. Then they were loaded with tumor antigen at different concentrations and cocultured with autologous T cells in 96-well flat-bottomed microtiter plates for five days at 37 degrees C, 5% CO(2). (3)H-thymine was added before the culture terminated, and twelve hours later, the cells were gathered to test the cpm value.
RESULTSBoth DCs and macrophages chased with tumor antigen could strongly stimulate the proliferation of autologous T cells, especially DCs. The stimulation effect with 20 microl/ml antigen was the most remarkable and the cmp values were 11,950.3 +/-1621.8, 8,708.5 +/-176.1, 402.5+/-43.1 in DCs group, Macrophages group, and lymphocytes group, respectively.
CONCLUSIONThe antigen presenting role of DCs is stronger than that of macrophages from the same individual.
Antigen Presentation ; immunology ; Antigen-Presenting Cells ; immunology ; physiology ; Antigens, Neoplasm ; immunology ; Carcinoma, Hepatocellular ; immunology ; Dendritic Cells ; immunology ; physiology ; Granulocyte-Macrophage Colony-Stimulating Factor ; pharmacology ; Humans ; Liver Neoplasms ; immunology ; Macrophages ; immunology ; physiology ; Tumor Cells, Cultured
3.Overview of Gp96 mediated immunity.
Caiwei CHEN ; Xiaojuan JIA ; Songdong MENG ; Wenjun LIU
Chinese Journal of Biotechnology 2011;27(5):704-711
As a member of the HSP90 family, heat shock protein (HSP) Gp96 is one of the most abundant proteins in the endoplasmic reticulum (ER), which displayed important molecular chaperones function in cells. Gp96 can stimulate the production of cytokines by activating the antigen presentation cells (such as dendritic cell, et al) in innate immunity. It is capable of eliciting an antigen-specific cytotoxic T lymphocyte (CTL) immune response to eliminate pathogens and tumors by facilitating antigen cross-presentation in adaptive immunity. Gp96 is also an ideal adjuvant in many recent researches. Here, we review the progress that addresses the role of biological characteristics, immunogenic mechanism that may be involved in the induction of anti-infection immune response and antitumor immunity, which may guide the new vaccine strategies with the knowledge of Gp96-antigen complexes.
Adjuvants, Immunologic
;
genetics
;
metabolism
;
Antigen-Presenting Cells
;
physiology
;
Communicable Diseases
;
immunology
;
Dendritic Cells
;
immunology
;
Endoplasmic Reticulum
;
immunology
;
Humans
;
Membrane Glycoproteins
;
immunology
;
Neoplasms
;
immunology
;
T-Lymphocytes, Cytotoxic
;
immunology
4.The phagocytosis of apoptotic allogeneic lymphocytes by recipient liver antigen-presenting cells.
Yan WANG ; Yi GAO ; Er-wei SUN ; Zhong-hua CHEN
Chinese Journal of Hepatology 2006;14(5):370-374
OBJECTIVETo track the location of the transfused apoptotic allogeneic lymphocytes and asses the process of their accumulation and phagocytosis removal as consequences on allograft tolerance in recipient mice.
METHODSDonor spleen lymphocytes were labeled by CFSE and induced to apoptosis by dexamethasone incubation. After purification by anti-annexin V-conjugated magnetic beads isolation, apoptotic lymphocytes were transfused into recipient mice through the tail veins. Tissue samples from various organs were taken at various time points to analyze the fates of the apoptotic allogeneic lymphocytes and the phagocytosis of them by organ resident APCs.
RESULTSUsing fluorescent microscopy and flow cytometry, after the apoptotic cells were recognized and uptaken, the largest amount of labeled cells were accumulated in the livers and disappeared within not more than 12 hours. Recipient liver APCs were highly efficacious in phagocytosis of apoptotic allogeneic lymphocytes; the removal was completed within 15 minutes after incubation. LSEC, KC and LDC all phagocytosized the apoptotic allogeneic lymphocytes but with significantly different rates. Considering the numbers of those cells in a normal liver, it could be calculated that LSEC and KC had greater effects in this activity.
CONCLUSIONSThe liver deserves foremost attention for study of the mechanism of allografts tolerance induced by pre-transfusion of apoptotic donor spleen lymphocytes. LSEC and KC are the main functional APCs to the alloantigens.
Animals ; Antigen-Presenting Cells ; cytology ; immunology ; Apoptosis ; physiology ; Liver ; cytology ; immunology ; Lymphocyte Transfusion ; Lymphocytes ; cytology ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Phagocytosis ; physiology ; Spleen ; cytology ; Transplantation, Homologous
5.Graft-versus-Leukemia Effect of Nonmyeloablative Stem Cell Transplantation.
Masahiro IMAMURA ; Junji TANAKA
The Korean Journal of Internal Medicine 2009;24(4):287-298
Nonmyeloablative stem cell transplantation (NST) is increasingly used with beneficial effects because it can be applied to older patients with hematological malignancies and those with various complications who are not suitable for conventional myeloablative stem cell transplantation (CST). Various conditioning regimens differ in their myeloablative and immunosuppressive intensity. Regardless of the type of conditioning regimen, graft-versus- host disease (GVHD) in NST occurs almost equally in CST, although a slightly delayed development of acute GVHD is observed in NST. Although graft-versus-hematological malignancy effects (i.e., graft-versus-leukemia effect, graft-versus-lymphoma effect, and graft-versus-myeloma effect) also occur in NST, completely eradicating residual malignant cells through allogeneic immune responses is insufficient in cases with rapidly growing disease or uncontrolled progressive disease. Donor lymphocyte infusion (DLI) is sometimes combined to support engraftment and to augment the graft-versus-hematological malignancy effect, such as the graft-versus-leukemia effect. DLI is especially effective for controlling relapse in the chronic phase of chronic myelogenous leukemia, but not so effective against other diseases. Indeed, NST is a beneficial procedure for expanding the opportunity of allogeneic hematopoietic stem cell transplantation to many patients with hematological malignancies. However, a more sophisticated improvement in separating graft-versus-hematological malignancy effects from GVHD is required in the future.
Antigen-Presenting Cells/physiology
;
Graft vs Host Disease/etiology
;
*Graft vs Leukemia Effect
;
Hematopoietic Stem Cell Transplantation/*adverse effects
;
Humans
;
Leukemia/therapy
;
Lymphocyte Transfusion
;
Lymphoma, Non-Hodgkin/therapy
;
Multiple Myeloma/therapy
;
*Transplantation Conditioning
6.Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction.
Quan-Sheng LIU ; Rui-Hua ZHANG ; Yi-Wei CHU ; Si-Dong XIONG
Acta Physiologica Sinica 2003;55(6):633-640
T cell anergy has been successfully induced under different conditions in cloned CD4(+) T cells, but induction of T cell anergy in vivo has been difficult and controversial. Due to the low frequency of naturally occurring T cell population with specificity to a defined antigen, it is very difficult to study anergy of naïve T cells without prior in vivo priming which complicates the interpretation of experimental data. To solve this problem, we adopted the HNT-TCR transgenic mice which have homogeneous antigen specific CD4(+) T cell population. In this study, we generated an influenza virus hemagglutinin (HA) peptide-specific CD4(+) T cell clone from the HNT-TCR transgenic mice and induced anergy using APCs which were treated with the crosslinker, ECDI (1-ethyl-3-3(3-dimethylaminopropyl) carbodiimide). The proliferative response of the cloned or freshly purified naïve CD4(+) transgenic T cells after treatment with ECDI-treated APCs and the HA peptide antigen was monitored as the index of anergy induction. The results showed that anergy was successfully induced in the cloned HNT-TCR transgenic CD4(+) T cells. It was determined that the induced anergy was antigen- and MHC-specific. By contrast, anergy was not observed in freshly purified naïve CD4(+) transgenic T cells under the same conditions. The results suggest that naïve CD4(+) T cells may have different anergy inducing requirements, or that cloned CD4(+) T cells may have certain priming or in vitro cloning artifact which makes them more susceptible to anergy induction. We propose that induction of T cell anergy may depend on the T cell growth, activation and differentiation state or cloning conditions. The results from the present study may have important implications for the study of the mechanism(s) underlying T cell anergy induction in vivo and for applications of immune tolerance based therapy.
Animals
;
Antigen-Presenting Cells
;
immunology
;
metabolism
;
Antigens, CD
;
genetics
;
immunology
;
metabolism
;
CD4 Antigens
;
immunology
;
CD4-Positive T-Lymphocytes
;
cytology
;
immunology
;
Clonal Anergy
;
genetics
;
immunology
;
Clone Cells
;
immunology
;
Epitopes, T-Lymphocyte
;
biosynthesis
;
Immune Tolerance
;
genetics
;
Major Histocompatibility Complex
;
immunology
;
Mice
;
Mice, Transgenic
;
Receptors, Antigen, T-Cell
;
physiology